Enteris BioPharma

Enteris Bio Pharma

Pharmaceuticals, 83 Fulton St., Boonton, , 7005, New Jersey, United States, 11-50 Employees

enterisbiopharma.com

  • twitter
  • LinkedIn

phone no Phone Number: 97********

Who is ENTERIS BIOPHARMA

Enteris BioPharma is a clinical stage biopharmaceutical company offering innovative formulation solutions built around its proprietary oral drug delivery technologies. In addition to its ...

Read More

map
  • 83 Fulton St., Boonton, New Jersey, 7005, United States Headquarters: 83 Fulton St., Boonton, New Jersey, 7005, United States
  • 2013 Date Founded: 2013
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ENTERIS BIOPHARMA

Enteris BioPharma Org Chart and Mapping

Employees

Raymundo Claudio

Senior Pharmaceutical Process Engineer II

Lynda Kolvik

Quality Control Tech Ll

Hector Castano

Senior Production Manufacturing Tech II

Amy Sturmer-Margulis

Director Bioanalytical Development

Tom Daggs

Vice President, Product Development & Quality Control

John Vrettos

Director, Formulation Development & Innovation

Andy Rasums

Director of Quality Assurance

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Enteris BioPharma

Answer: Enteris BioPharma's headquarters are located at 83 Fulton St., Boonton, , 7005, New Jersey, United States

Answer: Enteris BioPharma's phone number is 97********

Answer: Enteris BioPharma's official website is https://enterisbiopharma.com

Answer: Enteris BioPharma's revenue is $1 Billion and Over

Answer: Enteris BioPharma's SIC: 2834

Answer: Enteris BioPharma's NAICS: 325412

Answer: Enteris BioPharma has 11-50 employees

Answer: Enteris BioPharma is in Pharmaceuticals

Answer: Enteris BioPharma contact info: Phone number: 97******** Website: https://enterisbiopharma.com

Answer: Enteris BioPharma is a clinical stage biopharmaceutical company offering innovative formulation solutions built around its proprietary oral drug delivery technologies. In addition to its formulation development expertise, Enteris BioPharma has a 32,000 square foot GMP facility in Boonton, New Jersey, offering an expanding range of manufacturing and development services. Enteris BioPharma operates as an independent, wholly-owned subsidiary of SWK Holdings Corporation (SWKH.OB). Since its founding in 2013, Enteris has advanced into the clinic multiple internal and external programs leveraging its Peptelligence platform. The technology has been developed and proven effective over the last decade to enable the oral delivery of peptide-based therapeutics as well as other molecules with low oral bioavailability. Enteris BioPharmas internal clinical product pipeline consists of Ovarest (oral leuprolide tablet), currently being evaluated in for endometriosis, and TobrateTM (oral tobramycin tablet) for the treatment of uncomplicated urinary tract infection (uUTI). External market analyses demonstrate projected annual U.S. revenue potential for these two products approximate $1 billion in aggregate. Additionally, Enteris BioPharmas oral peptide delivery technology is the subject of several active externally sponsored pre-clinical and clinical development programs, the most advanced of which include R-Pharms TBRIA, an oral calcitonin for patients with postmenopausal osteoporosis, and an oral formulation of Cara Therapeutics KORSUVATM, a potent peripheral kappa opioid receptor agonist with a primary focus for the treatment of pruritus.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access